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Cholangiocarcinoma is rising in clinical imporrtance because of its increasing incidence, subroptimal response to therapy, and poor prognor
sis. Recent investigations into the underlying molecular 
mechanisms involved in cholangiocarcinogenesis and 
tumor growth have contributed greatly to our underr
standing of this disease.1,2 Conversion from normal to 
malignant bile epithelium probably requires a stepwise 
accumulation of successive genetic abnormalities inr
volving a variety of molecular defects of both oncogenes 
and tumor suppressor genes. However, the molecular 
pathogenesis of cholangiocarcinoma is still largely unr
known. 
The guanine nucleotiderbinding proteins (G pror
teins) play a key role in cell signaling. Its b and g subr
unit control the signals involved in cell growth. The Gr
g7 gene is widely distributed in the signal transduction 
pathways, and Grg7 rcoupled G proteins may contribr
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BACKGROUND AND OBjECTIvES: several studies have found a down-regulated G-g 7 gene in gastrointestinal 
tract cancers. We evaluated the expression and clinicopathological significance of the human G protein g 7 (G-g 
7) in human extra-hepatic cholangiocarcinoma (ehcc). 
METHODS: the expression of G-g 7 expression was studied in 21 patients with ehcc. G-g 7 mrna expres-
sion was tested by using realtime reverse transcription polymerase chain reaction (rt-pcr).to visualize the 
localization of G-g 7, an immunohistochemistry study was also performed. the G-g 7 expression was compared 
among cancer tissues, peri-cancerous bile duct tissues and normal bile duct tissues. the clinicopathological 
significance of G-g 7 expression was also studied.
RESULTS: expression of G-g 7 mrna and protein were significantly lower in ehcc tissue than in peri-cancerous 
bile duct tissue and normal bile duct tissues. G-g 7 mrna and protein expression were significantly lower in 
poorly differentiated ehcc tissues than in moderate differentiated and well differentiated ehcc tissues (P<.01). 
there was no significant correlation between G-g 7 expression and host factors such as age, gender, clinical 
staging or the status of preoperative hepatic function
CONCLUSIONS: ehcc has a down-regulated expression of G-g 7. reduced expression of G-g 7 is associated 
with the histological grade of ehcc and may prove to be a useful marker for predicting the prognosis of human 
ehcc.
ute to carcinogenesis in many cancers.3r5 Several studr
ies have found a downrregulated Grg7 gene in gastror
intestinal tract cancers, including esophageal, gastric, 
pancreatic, and colorectal cancers. To our knowledge, 
the expression of Grg7 hasn’t been confirmed in extrar
hepatic cholangiocarcinoma. In this study, we evaluated 
the expression of Grg7 in 21 extrarhepatic cholangior
carcinoma (EHCC) patients. The expression of Grg7 
was also compared among cancer tissues, perircancerr
ous normal bile duct tissue, and normal bile duct tisr
sues. The association of Grg7 and the histological grade 
of EHCC were also investigated.
METHODS
Twentyrone patients (14 male, 7 female) with disr
tal EHCC who underwent surgery at the Changhai 
Hospital, Shanghai Second Military Medical Universtiy, 
were studied. Mean age was 58.8 years. All patients unr
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derwent pancreaticoduodenectomy (Whipple procer
dure) for primary tumors not associated with primary 
sclerosing cholangitis. After the surgery, the tumor 
and corresponding nonrtumor tissues were immedir
ately frozen in liquid nitrogen and stored at –80ºC 
until use. Pericancerous normal bile duct tissue was 
taken from the area within 2 cm from the edge of canr
cer. Normal bile duct tissue was taken from the area 
at least 5 cm away from the edge of cancer. Clinical 
staging: 10 patients were stage IrII, 11 patients were 
stage IrII. The study has approved by the Specialty 
Committee on Ethics of Biomedicine, the Second 
Military Medical University.
RNA extraction and real time reverse stranscription 
(RT)sPCR analysis
Tissue samples were taken immediately after surgery 
and stored at –80ºC. RNA was extracted using the 
TRIzol reagent (TaKaRa Bio Inc. Japan) according 
to the manufacturer’s recommendations. The RNA 
was dissolved to 1(g/µL using diethylpyrocarbonater
treated water and stored at –80ºC until use.
Primer sequence was designed according to pubr
lished mRNA sequences of Grg7 gene (GenBank ID: 
NMr016373: 128bp 5’rTGTCAGCCACTAACAT
AGCCCAGGCCCGGAAGCTGGTGGAACAG
CTACGCATAGAAGCCGGGATTGAGCGCA
TCAAGGTCTCCAAAGCGGCGTCTGACCT
CATGAGCTACTGTGAGCAACATGCCr3’). 
The oligonucleotide primer pairs for Grg7 were synr
thesized (ShengGong Inc, China) (Sense primer: 5’r
TGTCAGCCACTAACAACATAGCr3’; antisense 
primer: 5’rGGCATGTTGCTCACAGTAGCr3’ ).
Grg7 mRNA extracted from 100mg tissues was 
prepared using the RNeasy Kit (Huashun, China), 
followed by reverse transcription into cDNA with 
oligordT primers (Takara Bio Inc, Japan). PCR 
was conducted in GeneAmp PCR system 2400 
(GeneAmp, USA). A reaction mix of 40 µL was prer
pared, incubated at 42ºC for 60min, reacted at 70ºC 
for 6min and then denatuated of reverse transcriptase. 
PCR was performed, in a total mix of 1 µL cDNA, 
dNTP, forward and reverse primers, and Taq polyr
merase (TakaRa Bio Inc, Japan). Positive and negative 
controls were included in all runs. The PCR was perr
formed using a method described previously.
Standard recombinant plasmid preparation: 
PCR product was cloned into the pMD18rT vecr
tor (Takara Bio Inc, Japan). The clones were inocur
lated into 100 µL Escherichia coli DH5a competent 
cells. White colonies were selected and screened by 
PCR. Briefly, white colonies were picked, incubated 
in Amp+ LB broth overnight at 37°C, 200 rpm/min. 
Plasmid DNA were extracted and purified according 
to recommendation of manufacturer (miniBest plasr
mid purification kit Ver 2.0, Takara Bio Inc, Japan). 
Followed by PCR amplification and agarose gel visur
alizing, the concentration of plasmid DNA was calcur
lated as 251.4 ng/µL. The plasmid DNA was diluted 
as 10r2, 10r3, 10r4, 10r5, 10r6 ng/µL to be used as 
standard benchmark.
Real time RTrPCR: PCR reactions containing 
SYBRrgreen were amplified on a Corbett Real Time 
PCR machine (Roche Diagonostics, USA). The 20 
µL Tag reaction mix included Grg7 forward and rer
verse primers and 1 µL standard plasmid or tissue. 
Realrtime quantification of cDNA was performed. 
Lingtcycler Version 5.32 was run to analyze the par
rameters to calculate the original concentration of the 
template.
Table 1.  The expression of g-g 7mrna in eHCC.
   Patient   
   No. Sex Age Histological grade
G-g 7 mRNA 
(×10-6 ng)
   1 F 70 poorly differentiated 0.7646
   2 M 74 Moderately differentiated 1.8030
   3 M 73 poorly differentiated 1.3230
   4 M 50 poorly differentiated 0.9248
   5 M 59 Well differentiated 3.7920
   6 F 50 poorly differentiated 1.4950
   7 F 38 Moderately differentiated 2.6140
   8 F 69 Moderately differentiated 2.0312
   9 F 65 Well differentiated 2.1215
   10 M 70 poorly differentiated 1.2112
   11 M 47 Moderately differentiated 1.9586
   12 F 43 Moderately differentiated 1.8659
   13 M 46 poorly differentiated 1.5642
   14 F 62 poorly differentiated 1.2456
   15 M 56 Well differentiated 2.0012
   16 M 70 poorly differentiated 0.9910
   17 M 64 Moderately differentiated 1.6258
   18 M 72 Well differentiated 2.8952
   19 M 47 poorly differentiated 1.1469
   20 M 58 Well differentiated 3.4216
   21 M 52 Well differentiated 2.9626
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Immunohistochemistry Staining
All tissue samples for immunohistochemical staining 
were fixed in buffered formalin, and embedded in parr
affin, and cut into 5¼mrthick slices. Prior to antirGg7 
immunostaining, endogenous peroxidase activity was 
blocked with 3% H2O
2 in water for 10 min. Heatrinr
duced epitope retrieval was performed with 1.0 mM 
EDTA buffer pH 8.0 for 10 min in a microwave oven 
Table 2. Quantitative comparison of g-g mrna expression.
                        mRNA (10-6 ng/µL) P value
   eHCC                     1.9000±0.8317 .001a
   peri-cancerous bile duct tissues 3.5920±0.8125 .002b
   normal bile duct tissues      3.4799±0.4463 .0069c
aeHCC compared with peri-cancerous bile duct tissue beHCC compared with normal bile duct tissue cperi-cancerous 
bile duct tissues compared with normal bile duct tissues.
Figure 1. g-g 7 was positive in normal bile duct tissues.
Figure 2. g-g 7 was negative in eHCC tissues.
followed by a 20rmin cooling down. In order to block 
nonspecific antibody binding, tissue samples were 
incubated with 10% goat serum in PBS for 30 min. 
Primary polyclonal rabbit Grg7 antibody was used at 
a 1:50 dilution overnight at 4ºC. Rabbit serum used 
as an isotype control at similar concentrations. This 
was followed by incubation with Envision HRP lar
beled polymer conjugated to goatrantirrabbit immur
noglobulins (Dako) for 30 min at room temperature. 
Staining development was performed with DAB with 
timed monitoring using a positive control sample. The 
slides were then counterstained with hematoxylin, der
hydrated, cleared, and mounted. These sections were 
read by a pathologist.
The clinicalpathological data variables were availr
able for evaluation. The data were compared between 
Grg7rpositive and Grg7rnegative patients. Spearman 
(nonparametric) correlation was used to correlate 
Grg7 expression with age, gender, tumor histological 
grade, tumor stage and the status of preoperative her
patic function. Fisher’s exact test was used in data nur
meration. The Frtest was used in data measurement. 
The basic significance level was at P<.05 and all data 
was analyzed using SPSS statistical software (Version 
11.0; SPSS Inc., Chicago, IL).
RESULTS 
The histological grading of extrarhepatic cholangiocarr
cinoma was as follows: 6 patients were Grade I (well 
differentiated); 6 were Grade II (moderately differenr
tiated), and 9 were Grade III (poorly differentiated). 
Gg 7 mRNA expression
EHCC samples expressed Grg7 mRNA at significantr
ly lower levels than perircancerous bile duct tissues 
and normal bile duct tissues. The average level of Gr
g7 mRNA was 1.9000±0.8317×10r6 ng/µL in EHCC 
tissues, 3.5920±0.8125×10r6 ng/µL in perircancerr
ous bile duct tissues, and 3.4799±0.4463r6 ng/µL in 
normal bile duct tissue samples (Tables 1, 2). Patient 
demographic information and histological grading are 
presented in Table 1.
Immunohistochemical staining
As shown in Figure 1, cells from five normal bile duct 
tissues have strong expression of cytoplasmic protein. 
In 21 primary EHCC tissues analyzed by immunor
histochemistry staining, Grg7 was weakly or moderr
ately expressed in 10 of the EHCC tissue samples. 
The positivity was linked to the tumor cells. Eleven 
EHCC samples had a negative staining of cytoplasmic 
protein (Figure 2). The negativity expression rate was 
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52.38% among EHCC tissue samples. Moreover, for 
these 11 negative samples, 1 was from a wellrdifferenr
tiated EHCC (1/6, 16.67%), 2 were from moderately 
differentiated EHCC (2/6, 33.33%), and 8 were from 
poorly differentiated EHCC (8/9, 88.89%).
Gsg 7 mRNA expression and clinicopathological data
The clinicopathological features analyzed in relar
tion to the Grg7 expression status are given in Table 
3. Spearman analysis found that expression of Grg7 
mRNA had a significant correlation with histological 
grading. The correlation coefficients were –0.911 and 
–0.506, respectively (P<.0001 and P=.008, respecr
tively). There was no significant correlation between 
Grg7 expression and host factors such as age, gender, 
clinical staging or the status of preoperative hepatic 
function (P>.05). Grg7 expression was significantly 
lower in poorly differentiated EHCC than in moderr
ately and wellrdifferentiated EHCC tissues (P<.05). 
DISCUSSION
The identification of the change of gene expression in 
tumor tissues and nonrtumor tissues is fundamental 
for understanding its biological mechanisms. G pror
teins are essential molecules in signal transduction 
pathways. Studies showed that Grg7 has specific regur
latory effects on adenylate cyclase signal transduction,6 
may stimulate receptor nucleotide exchange,7 and plays 
an important role in intracellular signal transduction 
and controls growth signals in cells. Downrregulation 
of Grg7 has been proved in several digestive organ 
cancers. In the present study, we studied the expresr
sion of Grg7 and its clinical significance in EHCC. 
Intrahepatic cholangiocarcinoma (IHCC) and exr
trahepatic cholangiocarcinoma are two closely related, 
but biologically unique neoplastic processes. This was 
supported by a prior study of methylation profiles of 
tumor suppressor genes in IHCC and EHCC.8 Study 
also revealed that p27 expression decreased progresr
sively from proximal to distal in the biliary tree and 
correlated with locationrrelated differences in outr
come. Cyclin D1 and Bcl2 overexpression also varied 
in the bile duct tissue according to anatomic site.9 In 
the present study, we demonstrated that the expresr
sion of Grg7 mRNA and its protein was strongly 
suppressed in EHCC tissues compared with normal 
bile duct tissues and perircancerous normal bile duct 
tissues. More than 50 per cent of EHCC tissues had 
a negative expression of Grg7 by immunohistochemir
cal study. The reduced expression of Grg7 was also 
confirmed by prior study in IHCC,10 which indicate 
that Grg7 may be the key point in the pathogenesis 
Table 3. Correlation of g-g 7 expression with clinic-pathological characteristics.
   Clinicopathological 
   characteristics
Case 
(No.)
G-g7 (Ct value) 
(×10-6) P value
   age
      >50y 14 2.0000±0.9342
.362
      <50y  7 1.7000±0.5600
   gender
      Male 14 1.7000±0.5981
.393
      Female  7 2.0000±0.9263
   Histological grade
      poorly differentiated  6 1.2000±0.2614 .000a
      Moderately differentiated  6 2.0000±0.3391
.020b
      Well differentiated  9 2.9000±0.7041
   Clinical Stage
       i + ii 10 1.8000±0.7913
.547
      iii + iV 11 2.0000±0.8906
   preoperation hepatic function
      normal  9 1.9000±0.6551
.850
      abnormal 12 1.9000±0.9712
apoorly-differentiated eHCC compared with moderately-differentiated eHCC  bModerately-differentiated eHCC 
compared with well-differentiated eHCC.
of IHCC and EHCC, and IHCC and EHCC may 
partially share a common molecular pathogenesis. The 
decreased expression of Grg7 has also been confirmed 
in pancreatic, esophageal and colon cancer tissues, 
further support that this is a common phenomenon 
in the process of tumorgenesis. Reduced expression 
of Grg7 is also correlated with loss of heterozygosity 
(LOH) and reduced transduction of growth inhibir
tion signal with cell contact.10r12 As a result, Grg7 has 
the potential to become the common target of genetic 
therapy to digestive tract cancers. 
In this study, we found that the expression of Grg7 
mRNA was not associated with patient age, gender, 
and preoperative liver function, but was associated 
with histological staging of the cancer. The expression 
of Grg7 mRNA was significantly lower in poorly difr
ferentiated EHCC than in moderately differentiated 
EHCC (P=.001). There was also statistically signifir
cant difference of Gr_7 expression in moderately difr
ferentiated and well differentiated cholangiocarcinor
ma (P=.020). Decreased expression of Grg7 protein 
has also been found in poorly differentiated IHCC 
than in moderately differentiated IHCC.10 Study has 
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also revealed that the expression of Grg7 can induce 
the expression of p27Kipl, the expression of p27Kipl is 
known to be related to survival in patients with various 
cancers, and the absent p27Kipl expression indepenr
dently predicted poor outcome.9 As a result, reduced 
Grg7 expression may through the reduced expression 
of p27 to affect the outcome of EHCC and IHCC. 
Since low expression of Grg7 is associated with poor 
histological grading, Grg7 might be also a predictive 
factor for disease progression and prognosis. 
In conclusion, expression of Grg7 mRNA was 
downrregulated in EHCC tissues and was clinically 
associated with its histological grade. The Grg7 exr
pression status may be used to predict the prognosis of 
human EHCC. Although the precise function of Gr
g7 in the pathogenesis of EHCC remains unclear, our 
discovery of aberrant expression of Grg7 in EHCC 
and its association with histological grade of EHCC 
make it an interesting gene that warrants further inr
vestigation.
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